Suchergebnisse - "Belada, David"

PubPharm (112)

1

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

enthalten in: Blood advances | 2024

von Tam, C. | Opat, S. | D'Sa, S. | +33

2

Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19 : a Czech retrospective multicenter study

enthalten in: Annals of hematology | 2024

von Demel, I. | Skopal, D. | Šafránková, E. | +15

3

Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study

enthalten in: Annals of hematology | 2023

von Demel, I. | Skopal, D. | Šafránková, E. | +15

4

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia : Final Analysis From the Randomized Phase III ASPEN Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Dimopoulos, M. | Opat, S. | D'Sa, S. | +31

5

Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL : the phase 1b First-MIND study

enthalten in: Blood | 2023

von Belada, D. | Kopeckova, K. | Bergua Burgues, J. | +13

CommentIn: Blood. 2023 Oct 19;142(16):1331-1332. - PMID 37856095

6

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203) : a phase 2 study

enthalten in: EClinicalMedicine | 2023

von Trněný, M. | Avigdor, A. | McKinney, M. | +14

7

A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia

enthalten in: Cancer medicine | 2023

von Vodárek, P. | Écsiová, D. | Řezáčová, V. | +6

8

Ibrutinib in mantle cell lymphoma : a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

enthalten in: Annals of hematology | 2023

von Obr, A. | Benesova, K. | Janikova, A. | +11

9

A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia

enthalten in: Cancer Medicine | 2023

von Vodárek, P. | Écsiová, D. | Řezáčová, V. | +6

10

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

enthalten in: Neoplasma | 2022

von Sýkorová, A. | Procházka, V. | Móciková, H. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]